Implementing a Nurse-Enabled, Shared-Care Model to Address Unmet Needs of People with Neuroendocrine Tumours – a randomised-controlled type II hybrid effectiveness-implementation trial (the AUS-NET trial)

Caring Futures Institute, College of Nursing and Health Sciences, Flinders University0 个研究点目标入组 510 人开始时间: 2023年8月2日最近更新: 2024年2月27日

适应症

试验速览

暂无简介。

•Patients aged 18 years of age or older
•- histologically confirmed neuroendocrine neoplasm (NENs) as per the 2017 World Health Organisation Classification:
•oWell differentiated neuroendocrine neoplasms: Neuroendocrine tumours (NET) (Grades 1-3)
•oPoorly differentiated neuroendocrine neoplasms: Neuroendocrine carcinoma (NEC)
•- can identify, or be willing to identify a usual General Practitioner or General Practice
•- ambulatory with ECOG performance status of 0-2
•- have access to a telephone or telehealth via smartphone, electronic tablet, personal computer, or equivalent, and
•- be able to speak and read English.

•- Patients diagnosed with pheochromocytoma or paraganglioma
•- Patients with small cell lung NEC or large cell lung NEC
•- Patients with severe mental, cognitive, or physical conditions or other circumstance that would limit their ability to participate at the discretion of the treating clinician
•- Patients judged to have <6 months of life expectancy at the discretion of the treating clinician
•- Patients judged to be unable to provide consent at the discretion of the treating clinician

发起方

Caring Futures Institute, College of Nursing and Health Sciences, Flinders University